2012 annual financial data
Aytu BioPharma 2012 Net income growth
Direct answer
Net income growth was 56.38%.
Operating income was -56,356 USD and net income was -59,675 USD.
Operating cash flow was -37,849 USD.
Get free Aytu BioPharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,750 USD
- Operating income
- -56,356 USD
- Net income
- -59,675 USD
- Operating cash flow
- -37,849 USD